ヒト・マイクロバイオームの世界市場:プロバイオティクス、食品、プレバイオティクス、医療食品、診断デバイス、医薬品、サプリメント

◆英語タイトル:Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (High Throughput, Omics Technology) - Global Forecast to 2023
◆商品コード:MAM-BT-2711
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年1月12日
◆ページ数:147
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD4,650 ⇒換算¥511,500見積依頼/購入/質問フォーム
Multi User (Five User)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD7,150 ⇒換算¥786,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、ヒト・マイクロバイオームの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、疾患別分析、用途別分析、製品別分析、技術別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The human microbiome market is segmented by application, disease, product, and geography while the human microbiome research spending market is broadly segmented by product and technology.

The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (2019–2023). The market is driven by growing incidences of unhealthy lifestyle diseases, and increase in occurrence of autoimmune disorders. However, government regulation and lack of detailed research may restrain the growth of this market to an extent. Investing in probiotic and prebiotic products, medical foods, drugs, and devices will prove fruitful for companies in the future.

The applications segment is further subdivided into therapeutics and diagnostics. Therapeutics may be the leading segment, owing to growing population and diseases. Currently, the diagnostics segment has fewer products in the pipeline than the therapeutics segment.

The products segment is subdivided into probiotics, prebiotics, foods, medical foods, other supplements, devices, and drugs. Growth in these segments will be majorly driven due to use of probiotics and prebiotics for maintaining gut flora to avoid lifestyle diseases.

The human microbiome research spending market, by product, is divided characterized into instruments and consumables. The instruments segment is further segmented into laboratory instruments and analyzers, while, the consumables segment is further bifurcated into kits and reagents. The consumables segment is estimated to be the fastest- growing segment by 2020, owing to the repeated purchases of consumables as compared to instruments.

The human microbiome research spending market, by technology, is divided into cell culture technology, high- throughput technology, omics technology, and computational tools. The cell culture technology is the most widely-used technology in microbiome research, and is expected to account for the largest share of the human microbiome research spending market in 2015. The large share of this segment can be attributed to its usage in the in vitro model to reproduce in vivo conditions and to study host-microbial community interactions.

The geographic analysis reveals that Europe will account for the largest share within the forecast period of 2019 to 2023, due to high acceptance of probiotic and prebiotic products. Asia is expected to be a profitable region for the human microbiome market and poised to grow at a healthy CAGR in the forecast period. North America will show a low market share; however, it is expected to grow at a high CAGR from 2019 to 2023.

The key players in the human microbiome market are Enterome Bioscience (France), Yakult Honsha Co., Ltd. (Japan), E. I. Du Pont de Nemours and company (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome, Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences, Inc. (U.S.), Osel, Inc. (U.S.), and Merck & Co, Inc. (U.S.)

【レポートの目次】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.3 Key Industry Insights
2.2.4 Assumptions

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 31)
4.1 Market Overview
4.2 Geographic Analysis: Market, By Product
4.3 Geographic Snapshot of the Market
4.4Market, By Product, 2019 vs 2023
4.5 Human Microbiome Research Spending Market, By Technology, 2015 vs 2020
4.6 Life Cycle Analysis

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Therapy, an Emerging Market
5.3.1.2 Human Microbiome as A New Validated Target
5.3.1.3 Need for Early Disease Detection and Diagnosis Driving the Use of Microbiomes in Molecular Diagnostics
5.3.2 Restraints
5.3.2.1 Lack of Expertise, Proper Detailed Research
5.3.2.2 Barriers to Prove Causal Link Between Dysbiosis and Disease
5.3.3 Opportunities
5.3.3.1 Investigational New Drug (IND) Requirements for Fecal Microbiota May Boost Market Growth
5.3.3.2 Joint Ventures, Collaborations, & Partnerships
5.3.4 Threats
5.3.4.1 Government Regulations
5.3.5 Burning Issues
5.3.5.1 Abundant Opportunities in the Microbiome Field and Tremendous Research Investments
5.3.5.2 Development of Microbiome Therapeutic Products

6 Human Microbiome Market, By Product (Page No. – 44)
6.1 Introduction
6.2 Probiotics
6.3 Foods
6.4 Prebiotics
6.5 Medical Foods
6.6 Diagnostic Devices
6.7 Drugs
6.8 Other Probiotic Supplements

7 Human Microbiome Market, By Application (Page No. – 54)
7.1 Introduction
7.2 Therapeutics
7.3 Diagnostics

8 Human Microbiome Market, By Disease (Page No. – 59)
8.1 Introduction
8.2 Acute Diarrhea
8.3 Obesity
8.4 Diabetes
8.5 Autoimmune Disorders
8.6 Cancer
8.7 Mental Disorders
8.8 Other Diseases

9 Human Microbiome Research Spending Market, By Product (Page No. – 70)
9.1 Introduction
9.2 Instruments
9.2.1 Laboratory Instruments
9.2.2 Analyzers
9.3 Consumables
9.3.1 Kits
9.3.2 Reagents

10 Human Microbiome Research Spending Market, By Technology (Page No. – 80)
10.1 Introduction
10.2 Cell Culture Technology
10.3 High-Throughput Technology
10.4 Omics Technology
10.5 Computational Tools

11 Geographic Analysis (Page No. – 88)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 112)
12.1 Overview
12.2 Competitive Situation and Trends
12.2.1 Agreements, Partnerships, and Collaborations
12.2.2 Acquisitions & Expansions
12.2.3 New Product Launches, Product Approvals, and Patents
12.2.4 Other Developments

13 Company Profiles (Page No. – 119)
13.1 Geographic Revenue Mix of the Three Market Players
13.2 Enterome Bioscience
13.2.1 Business Overview
13.2.2 Financials
13.2.3 Products Offered
13.2.4 Recent Developments
13.2.5 MnM View
13.3 E.I. Du Pont De Nemours and Company
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Merck & Co., Inc.
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Metabiomics Corporation
13.5.1 Business Overview
13.5.2 Financials
13.5.3 Products Offered
13.5.4 Recent Developments
13.5.5 MnM View
13.6 Yakult Honsha Co., Ltd.
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM View
13.7 Microbiome Therapeutics, Llc
13.7.1 Business Overview
13.7.2 Financials
13.7.3 Products Offered
13.7.4 Recent Developments
13.8 Osel, Inc.
13.8.1 Business Overview
13.8.2 Financials
13.8.3 Products Offered
13.8.4 Recent Developments
13.9 Second Genome, Inc.
13.9.1 Business Overview
13.9.2 Financials
13.9.3 Products Offered
13.9.4 Recent Developments
13.10 Vithera Pharmaceuticals
13.10.1 Business Overview
13.10.2 Financials
13.10.3 Products Offered
13.10.4 Recent Developments
13.11 Vedanta Biosciences, Inc.
13.11.1 Business Overview
13.11.2 Financials
13.11.3 Products Offered
13.11.4 Recent Developments

14 Appendix (Page No. – 140)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports

List of Tables (89 Tables)

Table 1 Use of Microbiome in Early Disease Detection and Diagnosis, A Key Driver to the Growth of the Market
Table 2 Lack of Proper Detailed Research Curbs Market Growth
Table 3 Significant Impact of Regulatory Authorities May Boost Market Growth
Table 4 Modification of Regulatory Pathways By the Fda May Hamper the Growth of the Market
Table 5 Market Size, By Product, 2019–2023 (USD Million)
Table 6 Market Size for Probiotics, By Region, 2019-2023 (USD Million)
Table 7 Human Microbiome Foods Market, By Region, 2019-2023 (USD Million)
Table 8 Market Size for Prebiotics, By Region, 2019-2023 (USD Million)
Table 9 Market Size for Medical Foods, By Region, 2019-2023 (USD Million)
Table 10 Market Size for Diagnostic Devices, By Region, 2019–2023 (USD Million)
Table 11 Market Size for Drugs, By Region, 2019–2023 (USD Million)
Table 12 Market Size for Other Probiotic Supplements, By Region, 2019-2023 (USD Million)
Table 13 Market Size, By Application, 2019–2023 (USD Million)
Table 14 Market Size for Therapeutic Applications, By Region, 2019–2023 (USD Million)
Table 15 Market Size for Diagnostic Applications, By Region, 2019–2023 (USD Million)
Table 16 Market Size, By Disease, 2019–2023 (USD Million)
Table 17 Market Size for Acute Diarrhea, By Region, 2019–2023 (USD Million)
Table 18 Market Size for Obesity, By Region, 2019–2023 (USD Million)
Table 19 Market Size for Diabetes, By Region, 2019–2023 (USD Million)
Table 20 Market Size for Autoimmune Disorders, By Region, 2019–2023 (USD Million)
Table 21 Market Size for Cancer, By Region, 2019–2023 (USD Million)
Table 22 Market Size for Mental Disorders, By Region, 2019–2023 (USD Million)
Table 23 Market Size for Other Diseases, By Region, 2019–2023 (USD Million)
Table 24 Human Microbiome Research Spending Market Size, By Product, 2013–2020 (USD Million)
Table 25 Human Microbiome Research Spending Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 26 Market Size for Instruments, By Region, 2013–2020 (USD Million)
Table 27 North America: Market Size for Instruments, By Country, 2013–2020 (USD Million)
Table 28 Market Size for Laboratory Instruments, By Region, 2013–2020 (USD Million)
Table 29 North America: Market Size for Laboratory Instruments, By Country, 2013–2020 (USD Million)
Table 30 Human Microbiome Research Spending Market Size for Analyzers, By Region, 2013–2020 (USD Million)
Table 31 North America: Market Size for Analyzers, By Country, 2013–2020 (USD Million)
Table 32 Size for Consumables, By Type, 2013–2020 (USD Million)
Table 33 Market Size for Consumables, By Region, 2013–2020 (USD Million)
Table 34 North America: Market Size for Consumables, By Country, 2013–2020 (USD Million)
Table 35 Market Size for Kits, By Region, 2013–2020 (USD Million)
Table 36 North America: Human Microbiome Research Spending Market Size for Kits, By Country, 2013–2020 (USD Million)
Table 37 Market Size for Reagents, By Region, 2013–2020 (USD Million)
Table 38 North America: Market Size for Reagents, By Country, 2013–2020 (USD Million)
Table 39 Market Size, By Technology, 2013–2020 (USD Million)
Table 40 Market Size for Cell Culture Technology, By Region, 2013–2020 (USD Million)
Table 41 North America: Human Microbiome Research Spending Market Size for Cell Culture Technology, By Country, 2013–2020 (USD Million)
Table 42 Market Size for High-Throughput Technology, By Region, 2013–2020 (USD Million)
Table 43 North America: Market Size for High-Throughput Technology, By Country, 2013–2020 (USD Million)
Table 44 Market Size for Omics Technology, By Region, 2013–2020 (USD Million)
Table 45 North America: Market Size for Omics Technology, By Country, 2013–2020 (USD Million)
Table 46 Market Size for Computational Tools, By Region, 2013–2020 (USD Million)
Table 47 North America: Human Microbiome Research Spending Market Size for Computational Tools, By Country, 2013–2020 (USD Million)
Table 48 Human Microbiome Market Size, By Region, 2019–2023 (USD Million)
Table 49 Human Microbiome Research Spending Market Size, By Region, 2013–2020 (USD Million)
Table 50 North America: Human Microbiome Market Size, By Product, 2019–2023 (USD Million)
Table 51 North America: Human Microbiome Market Size, By Application, 2019–2023 (USD Million)
Table 52 North America: Human Microbiome Market Size, By Disease, 2019–2023 (USD Million)
Table 53 North America: Human Microbiome Research Spending Market Size, By Product, 2013–2020 (USD Million)
Table 54 North America: Human Microbiome Research Spending Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 55 North America: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 56 North America: Market Size, By Technology, 2013–2020 (USD Million)
Table 57 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 58 U.S.: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 59 U.S.: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 60 U.S.: Market Size, By Technology, 2013–2020 (USD Million)
Table 61 Canada: Spending Market Size, By Product, 2013–2020 (USD Million)
Table 62 Canada: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 63 Canada: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 64 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 65 Europe: Human Microbiome Market Size, By Product, 2019–2023 (USD Million)
Table 66 Europe: Human Microbiome Market Size, By Application, 2019–2023 (USD Million)
Table 67 Europe: Human Microbiome Market Size, By Disease, 2019–2023 (USD Million)
Table 68 Europe: Human Microbiome Research Spending Market Size, By Product, 2013–2020 (USD Million)
Table 69 Europe: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 70 Europe: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 71 Europe: Market Size, By Technology, 2013–2020 (USD Million)
Table 72 Asia-Pacific: Human Microbiome Market Size, By Product, 2019–2023 (USD Million)
Table 73 Asia-Pacific: Human Microbiome Market Size, By Application, 2019–2023 (USD Million)
Table 74 Asia-Pacific: Human Microbiome Market Size, By Disease, 2019–2023 (USD Million)
Table 75 APAC: Human Microbiome Research Spending Market Size, By Product, 2013–2020 (USD Million)
Table 76 APAC: Human Microbiome Research Spending Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 77 APAC: Human Microbiome Research Spending Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 78 APAC: Human Microbiome Research Spending Market Size, By Technology, 2013–2020 (USD Million)
Table 79 RoW: Human Microbiome Market Size, By Product, 2019–2023 (USD Million)
Table 80 RoW: Human Microbiome Market Size, By Application, 2019–2023 (USD Million)
Table 81 RoW: Human Microbiome Market Size, By Disease, 2019–2023 (USD Million)
Table 82 RoW: Human Microbiome Research Spending Market Size, By Product, 2013–2020 (USD Million)
Table 83 RoW: Human Microbiome Research Spending Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 84 RoW: Human Microbiome Research Spending Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 85 RoW: Human Microbiome Research Spending Market Size, By Technology, 2013–2020 (USD Million)
Table 86 Agreements, Partnerships, and Collaborations , 2012–2015
Table 87 Acquisitions & Expansions, 2012-2015
Table 88 New Product Launches, Product Approvals, and Patents, 2012–2015
Table 89 Other Developments, 2012–2015

List of Figures (46 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation and Data Triangulation Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Human Microbiome Market Snapshot (2019 vs 2023)
Figure 6 Probiotics Segment to Dominate the Human Microbiome Market During the Forecast Period
Figure 7 Consumables Segment to Witness the Highest Growth Rate in the Microbiome Research Spending Market From 2015 to 2020
Figure 8 Cell Culture Technologies to Dominate the Human Microbiome Research Spending Market in 2015
Figure 9 Geographical Snapshot of the Global Human Microbiome Market, 2019
Figure 10 Agreements, Partnerships, and Collaborations - Dominant Strategy Pursued By Market Players
Figure 11 Growing Prevalence of Lifestyle Diseases and Increasing Acceptance of Microbiome-Based Products are Major Growth Drivers
Figure 12 Pr0biotics Segment to Account for the Largest Share of the Market in 2019
Figure 13 North America Poised to Be the Fastest-Growing Market From 2019 to 2023
Figure 14 Prebiotics Segment Poised to Grow at the Highest CAGR From 2019 to 2023
Figure 15 Cell Culture Technologies Segment to Dominate the Microbiome Research Spending Technology Market in 2015
Figure 16 North America to Enter Exponential Growth Phase
Figure 17 Human Microbiome as A New Validated Target for Drug Development May Spur the Market
Figure 18 Funds Provided for Microbiome Research By Various Medical Research Agencies
Figure 19 Probiotics Expected to Dominate the Human Microbiome Market During the Forecast Period
Figure 20 Europe Will Account for the Largest Share of the Probiotics Market in 2019
Figure 21 North America Expected to Dominate the Human Microbiome Foods Market From 2019 to 2023
Figure 22 Inorganic Growth Strategies Between Companies Will Increase the Demand for Microbiome-Based Drugs in Europe
Figure 23 The Therapeutics Segment to Command the Largest Share of the Human Microbiome Applications Market By 2023
Figure 24 Europe to Account for the Largest Share of the Therapeutics Application Segment in 2019
Figure 25 Acute Diarrhea Expected to Be the Largest Disease Segment of the Human Microbiome Market in 2019
Figure 26 Europe is Estimated to Be the Largest Human Microbiome Market for Acute Diarrhea in 2019
Figure 27 Human Microbiome Market for Obesity is Expected to Witness Highest Growth Rate in North America During the Forecast Period
Figure 28 Instruments Segment to Dominate the Human Microbiome Research Spending Market, By Product
Figure 29 Europe to Account for the Largest Share of the Instruments Segment in 2015
Figure 30 North America to Witness the Highest Growth in the Consumables Market From 2015 to 2020
Figure 31 Cell Culture Technology Segment to Grow at the Highest Rate From 2015 to 2020
Figure 32 Europe to Account for the Largest Share of the Cell Culture Technology Segment in 2015
Figure 33 U.S. to Account for the Largest Share of the North American High-Throughput Technology Market By 2020
Figure 34 Canada to Grow at the Highest Rate During the Forecast Period
Figure 35 North America Will Be the Fasted-Growing Region in the Computational Tools Market From 2015 to 2020
Figure 36 Geographic Snapshot (2019): North America Will Be the Fastest-Growing Region By 2019
Figure 37 North America Shows High Growth Potential for the Human Microbiome Research Spending Market
Figure 38 Demand for Human Microbiome Will Be Fueled By Growing R&D and Rising Incidences of Lifestyle Diseases and Chronic Disorders
Figure 39 Europe: Market Snapshot
Figure 40 Prebiotics Segment to Grow at the Fastest Rate in the APAC Human Microbiome Product Market From 2019 to 2023
Figure 41 Cell Culture Technology is the Most Commonly Used Technology for Human Microbiome Research in 2015
Figure 42 Companies Adopted Agreements, Collaborations, and Partnerships as Their Key Growth Strategy Over the Last Three Years
Figure 43 Battle for Market Share: Agreements, Collaborations, and Partnerships - Key Growth Strategy Adopted By Players in the Human Microbiome Market
Figure 44 E.I. Du Pont De Nemours and Company: Company Snapshot
Figure 45 Merck & Co., Inc.: Company Snapshot
Figure 46 Yakult Honsha Co., Ltd.: Company Snapshot

【レポートのキーワード】

ヒト・マイクロバイオーム、微生物、プロバイオティクス、食品、プレバイオティクス、医療食品、診断デバイス、医薬品、サプリメント、治療、検査、診断、医療、急性下痢、肥満、糖尿病、マイクロバイオーム用途

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[ヒト・マイクロバイオームの世界市場:プロバイオティクス、食品、プレバイオティクス、医療食品、診断デバイス、医薬品、サプリメント]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年05月27日現在 190,338 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆